DAB.bio
Unlocking the promise of biomanufacturing by transforming the economics of production with our patented FAST bioreactor
DAB is a leading expert in Separation Technology of oil based fermentation. Our unique and patented FAST technology (Fermentation Accelerated by Separation Technology) enables continuous fermentation to offer unit cost reductions of 30% or more. By continuously removing product or inhibitors from the fermentation process, FAST extends the run time and increases unit production. FAST has become one the most significant fermentation innovations of the past decade. This technology can easily be implemented in new and existing installations, allowing for rapid application.
The global focus on synthetic biology has delivered several breakthrough routes to replace fossil-based chemicals with sustainable bio-based alternatives. High manufacturing costs currently hamper the large-scale manufacturing of many of these alternatives. FAST addresses this issue head-on. It is the largest contributor to lowering manufacturing costs, thereby facilitating large-scale deployment of many bio-based chemicals.
DAB has a highly skilled workforce and is supported by driven and capable investors.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
One year later: Insights from Scale-up frontrunners | Martijn Bekker (WFBR)
Martijn Bekker, expertise leader microbial cell factories, from the Wageningen Food & Biobased Research (WFBR), shares his 2025 improvements and is confident that the use of optical spectroscopy will mean a new way of working for industrial fermentation processes within the next few years.
Fenneke Jolink
VACANCY | Science and Innovation Manager
Planet B.io is looking for a Science and Innovation manager to support and grow our community of start-ups, scale-ups, and corporates in the biotech and foodtech sector.
One year later: Insights from Scale-up frontrunners | Mickel Jansen (dsm-firmenich)
Mickel Jansen, Principal Scientist BioProcess Development of dsm-firmenich, shares last year’s improvements and reflects on scaling, innovation, and keeping the end in mind.
Fenneke Jolink